Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by PutinKhuylo1on Aug 29, 2017 1:24pm

156 Views

Post# 26633167

RE:RE:RE:RE:RE:Pathetic

Exactly Dachs1. Present a signed licensing agreement in the hundreds of millions and all will be forgiven lol.
What I see as the biggest problem is the lack of in-house IR. A seasoned veteran, with easy access to all the players, who can answer the phones on a daily basis and actually provide accurate and timely information. The good ones get to know all the shareholders and develop relationships that are beneficial to both the company and the investor. The lack of communication is our biggest problem.
My 2 cents.

Bullboard Posts

A Look into the Future of Chronic Pain Management